XML 100 R34.htm IDEA: XBRL DOCUMENT v3.20.1
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2019
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Summary of Fair Value of Stock Options Issued to Employees

The fair value of stock option issued to employees was estimated at the date of grant using Black-Scholes with the following weighted-average assumptions:

 

 

 

For the Year Ended December 31,

 

 

 

2019

 

 

2018

 

Expected volatility

 

 

92.68

%

 

 

92.14

%

Expected term (years)

 

 

5.89

 

 

 

6.07

 

Risk-free interest rate

 

 

2.17

%

 

 

2.86

%

Expected dividend yield

 

 

0.00

%

 

 

0.00

%

Schedule of Information Related to Stock Options Outstanding

A summary of stock option activities under the Plans is presented below:

 

 

 

Number of

Stock Options

 

 

Weighted-

Average

Exercise Price

 

 

Weighted-Average

Remaining

Contractual Term

(Year)

 

 

Weighted-

Average Intrinsic

Value

 

Outstanding, January 1, 2019

 

 

353,274

 

 

$

10.97

 

 

 

6.04

 

 

$

-

 

Granted

 

 

725,000

 

 

 

2.67

 

 

 

 

 

 

 

 

 

Exercised

 

 

 

 

 

 

 

 

 

 

 

 

$

-

 

Forfeited or expired

 

 

(105,102

)

 

 

14.89

 

 

 

 

 

 

 

 

 

Outstanding, December 31, 2019

 

 

973,172

 

 

$

4.36

 

 

 

5.91

 

 

$

-

 

Exercisable, December 31, 2019

 

 

289,518

 

 

$

6.86

 

 

 

5.48

 

 

$

-

 

Expected to vest, December 31, 2019

 

 

594,779

 

 

$

3.30

 

 

 

6.09

 

 

$

-

 

Summary of Restricted Stock Activity

A summary of restricted stock activities is presented below:

 

 

Shares

 

 

Weighted-

average

Grant Date

Fair Value

 

Unvested, January 1, 2019

 

 

323,404

 

 

$

4.06

 

Vested

 

 

(87,738

)

 

 

4.58

 

Unvested, December 31, 2019

 

 

235,666

 

 

$

3.87

 

Schedule of Stock-based Compensation Expense

Stock-based compensation expense is classified in the accompanying consolidated statements of operations and comprehensive loss for the years ended December 31, 2019 and 2018 as follows:

 

 

 

Year-Ended December 31,

 

 

 

2019

 

 

2018

 

Research and development

 

$

356,718

 

 

$

319,354

 

General and administrative

 

 

907,513

 

 

 

453,894

 

Total

 

$

1,264,231

 

 

$

773,248